Clinical Trial Update: A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of Vitreosolve for non-proliferative diabetic retinopathy, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Vitreosolve

Snippet

Sponsor: Vitreoretinal Technologies, Inc. | Conditions: Diabetic Retinopathy | Phase 3 | Status: UNKNOWN